Clinical Trials Browser

Interventional × Seminoma × ARQ 197 × Clear all

NCT01055067 2021-04-06

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Phase 2 Terminated

27 enrolled 6 charts

Seminoma